Loulla-Philla

Cardinal Systems is proud to be participating in the launch of the FP7's Loulla & Philla website.

Loulla & Philla is a European project funded by the European Commission through the 7th Framework Programme for Research and Development.

The aim of the project is the development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukemia in children.

Document Actions

Partners & Working Groups

Cardinal Systems works in partnership with O4CP for the Loulla & Philla FP7 project.

Cardinal Systems has been supporting France Biotech since 2001, and works closely with governmental institutions implicated in the valorisation of innovation, such as Oseo, Comite Richelieu (Pactepme) and Medicen.

Partners

Cardinal Systems participates actively in working groups, such as DIA, PSI and CDISC.

Working Groups